Paper Details

  1. Home
  2. Paper Details

Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine.

Author: DemitrackMark A, DetkeMichael J, GoldsteinDavid J, LuYili, MallinckrodtCraig, WiltseCurtis

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine, is effective for treating both emotional and physical symptoms of depression, with a side effect profile similar to selective serotonin reuptake inhibitors.
Paper Details　
Original Abstract of the Article :
CONTEXT: Major depressive disorder causes significant morbidity and mortality. Current therapies fail to fully treat both emotional and physical symptoms of major depressive disorder. OBJECTIVE: To evaluate duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine, on improvement of emo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1097/01.jcp.0000132448.65972.d9

データ提供：米国国立医学図書館（NLM）

Duloxetine: A Light in the Desert of Depression?

The world of depression is a vast and often unforgiving desert, where sufferers struggle with both emotional and physical pain. This research, like a refreshing oasis, seeks to provide relief for those lost in the desert of depression. The study focuses on duloxetine, a dual reuptake inhibitor, and its impact on both emotional and physical symptoms. Using a double-blind, placebo-controlled comparison with paroxetine, the researchers discovered duloxetine's potential in alleviating the symptoms of depression. Their findings suggest that duloxetine may be a valuable tool in the fight against this debilitating condition.

Duloxetine Offers Hope for Depression Sufferers

The results of this study show that duloxetine significantly improved the symptoms of depression in those who took it. In fact, those who took the higher dose of duloxetine (80 mg/day) experienced a greater improvement in their depression scores compared to those who took a placebo or paroxetine. This could signify a brighter future for those seeking relief from the depths of depression.

Easing the Burden of Depression, One Camel Step at a Time

Depression is a complex condition with a multitude of symptoms, both emotional and physical. Duloxetine, with its dual reuptake inhibitor action, may offer a more holistic approach to treatment, addressing both the emotional and physical aspects of depression. This could translate to a more comfortable journey for those seeking relief from the desert of depression.

Dr. Camel's Conclusion

This study provides promising evidence for duloxetine's effectiveness in treating both emotional and physical symptoms of depression. It's like finding a hidden spring in the middle of the desert - a source of hope and relief for those struggling with this condition. While more research is always needed, this research provides a reason for optimism in the fight against depression.

Date :
  1. Date Completed 2004-11-04
  2. Date Revised 2022-03-10
Further Info :

Pubmed ID

15232330

DOI: Digital Object Identifier

10.1097/01.jcp.0000132448.65972.d9

Related Literature

Article Analysis
・Effective treatment of depression
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.